← Leaderboards
Earl R Kern
University Of Alabama At Birmingham
$1,652,748
Attributed
$1,652,748
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,652,748 · 3
By mechanism
N01$1,324,230 · 2
U01$328,518 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- William J Britt$28,989,956
- Bernard Roizman$20,026,247
- Mark R Walter$8,091,625
- Kenneth G Lucas$2,028,141
- Suresh B Boppana$9,522,148
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationTissue /Cell CultureAntiviral AgentsCooperative StudyPoxviridaeHerpes Simplex Virus 2HerpesviridaeHuman Herpesvirus 6Human Herpesvirus 8Varicella Zoster VirusBiomedical FacilityCytomegalovirusEpstein Barr VirusHerpes Simplex Virus 1
Grant awards (6)
Antiviral activity toward vaccinia and cowpox viruses$109,506
U01 · FY2002 · AI
Antiviral activity toward vaccinia and cowpox viruses$109,506
U01 · FY2001 · AI
IN VITRO ANTIVIRAL SCREEN FOR HERPESVIRUSES$621,856
N01 · FY2000 · AI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS$560,186
N01 · FY2000 · AI
IN VITRO ANTIVIRAL SCREEN FOR HERPESVIRUSES$142,188
N01 · FY2000 · AI
Antiviral activity toward vaccinia and cowpox viruses$109,506
U01 · FY2000 · AI